June 5, 2023
Protected: State of the Tools & Dx Industry – It is Still Too Early to Call the Bottom – June 2nd – REPLAY
May 12, 2023
Protected: Outlook for Lawsuit Challenging Power of CMS, HHS & Other Regulators to Set Government Policy – May 11th – REPLAY
April 24, 2023
Protected: Broad Institute Discussion on NGS Innovation & Genomics – Apr. 21 – REPLAY
April 13, 2023
Protected: Nephron FDA KOL Call on CRC Liquid Biopsy Tests – Apr. 12th – REPLAY
April 6, 2023
Protected: Nephron NGS industry KOL Discussion – Apr. 5th – REPLAY
March 21, 2023
340B Pharmacy Tailwind/Manufacturer Headwind Poised to Reverse in 2H 2023
March 6, 2023
Protected: Generic Market Dynamics Expert Call – Mar. 3rd – REPLAY
February 25, 2023
Comprehensive Market Update – CRO Industry 2023
February 17, 2023
Protected: Nephron MA Innovation Series: René Lerer – CEO Longevity Health Plan – Feb. 15th – REPLAY
February 14, 2023
MedTech Matchmaker – 5 Deal Ideas for 2023
February 9, 2023
Nephron Research Ranked #1 By Institutional Investor
February 7, 2023
Next Big Things: Why Pulsed Field Ablation Will Revolutionize the Treatment of AF
February 7, 2023
Protected: Understanding the PFA Competitive Landscape – Feb. 7th – REPLAY
February 3, 2023
Protected: Nephron Expert Call: Humira Biosimilar Launch Dynamics – Feb. 3rd – REPLAY
January 20, 2023
Protected: Nephron KOL Call on Lab/Dx Industry Updates – Jan. 19th – REPLAY